Trials / Completed
CompletedNCT01702025
Rapid Acclimatization to Hypoxia at Altitude
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Colorado State University · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
In low oxygen environments, such as altitude, some adults may become ill and suffer from acute mountain sickness. Further, all adults will find that exercising becomes much more difficult when compared with exercise at lower altitudes (e.g. sea-level). The purpose of this investigation is to study the effects of two drugs that may help people adjust to high-altitude quickly, prevent them from becoming ill and improve their exercise performance. The drugs are Methazolamide and Aminophylline.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Yellow corn meal in gel capsules |
| DRUG | Aminophylline | National Drug Code (NDC) 0143-1020-01 |
| DRUG | Methazolamide | NDC 0781-1072-01 |
| DRUG | Aminophylline+Methazolamide | NDC 0143-1020-01 and NDC 0781-1072-01 |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2012-10-05
- Last updated
- 2014-10-24
- Results posted
- 2014-10-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01702025. Inclusion in this directory is not an endorsement.